BRPI0514672A - polipeptìdeos de fusobacterium e métodos de uso - Google Patents

polipeptìdeos de fusobacterium e métodos de uso

Info

Publication number
BRPI0514672A
BRPI0514672A BRPI0514672-0A BRPI0514672A BRPI0514672A BR PI0514672 A BRPI0514672 A BR PI0514672A BR PI0514672 A BRPI0514672 A BR PI0514672A BR PI0514672 A BRPI0514672 A BR PI0514672A
Authority
BR
Brazil
Prior art keywords
methods
polypeptides
fusobacterium
fusobacterium polypeptides
present
Prior art date
Application number
BRPI0514672-0A
Other languages
English (en)
Inventor
Daryll A Emery
Darren E Straub
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of BRPI0514672A publication Critical patent/BRPI0514672A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

POLIPEPTìDEOS DE FUSOBACTERIUM E MéTODOS DE USO A presente invenção fornece polipeptídeos isolados isoláveis a partir de Fusobacterium spp. Também são fornecidas pela presente invenção composições que incluem um ou mais dos polipeptídeos e métodos para fazê-las e métodos para usar os polipeptídeos.
BRPI0514672-0A 2004-08-25 2005-08-25 polipeptìdeos de fusobacterium e métodos de uso BRPI0514672A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60434904P 2004-08-25 2004-08-25
PCT/US2005/030290 WO2006026373A1 (en) 2004-08-25 2005-08-25 Fusobacterium polypeptides and methods of use

Publications (1)

Publication Number Publication Date
BRPI0514672A true BRPI0514672A (pt) 2008-06-17

Family

ID=35385423

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514672-0A BRPI0514672A (pt) 2004-08-25 2005-08-25 polipeptìdeos de fusobacterium e métodos de uso

Country Status (9)

Country Link
US (4) US9458204B2 (pt)
EP (1) EP1784417B1 (pt)
AU (1) AU2005280147B2 (pt)
BR (1) BRPI0514672A (pt)
CA (1) CA2578041C (pt)
ES (1) ES2587365T3 (pt)
MX (1) MX2007001886A (pt)
NZ (1) NZ553315A (pt)
WO (1) WO2006026373A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE352314T1 (de) * 1994-02-09 2007-02-15 Epitopix Llc Aktive immunisierung gegen ein siderophores rezeptorprotein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
DK1353689T3 (da) 2001-01-03 2006-07-31 Epitopix Llc Immuniseringspræparater og anvendelse deraf
US7641780B2 (en) 2001-05-01 2010-01-05 Calibrant Biosystems, Inc. Two-dimensional microfluidics for protein separations and gene analysis
BRPI0514672A (pt) * 2004-08-25 2008-06-17 Epitopix Llc polipeptìdeos de fusobacterium e métodos de uso
WO2006079076A2 (en) * 2005-01-21 2006-07-27 Epitopix, Llc Yersinia spp. polypeptides and methods of use
US20080156080A1 (en) * 2007-01-02 2008-07-03 Calibrant Biosystems, Inc. Methods and systems for multidimensional concentration and separation of biomolecules using capillary isotachophoresis
US20080160629A1 (en) * 2007-01-02 2008-07-03 Calibrant Biosystems, Inc. Methods and systems for off-line multidimensional concentration and separation of biomolecules
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
BR112018009319A8 (pt) 2015-11-09 2019-02-26 Epitopix Llc polipeptídeos de fusobacterium e métodos de uso
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
ATE352314T1 (de) * 1994-02-09 2007-02-15 Epitopix Llc Aktive immunisierung gegen ein siderophores rezeptorprotein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6632439B2 (en) * 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
EP1283717B1 (en) * 2000-04-25 2010-09-08 Kansas State University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
US6669940B2 (en) * 2000-04-25 2003-12-30 Kansas University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
DK1353689T3 (da) * 2001-01-03 2006-07-31 Epitopix Llc Immuniseringspræparater og anvendelse deraf
WO2005028665A2 (en) * 2003-09-19 2005-03-31 Epitopix, Llc Campylobacter polypeptides and methods of use
BRPI0514672A (pt) * 2004-08-25 2008-06-17 Epitopix Llc polipeptìdeos de fusobacterium e métodos de uso

Also Published As

Publication number Publication date
US9487564B2 (en) 2016-11-08
CA2578041A1 (en) 2006-03-09
US9458204B2 (en) 2016-10-04
WO2006026373A1 (en) 2006-03-09
US20160376327A1 (en) 2016-12-29
US10183974B2 (en) 2019-01-22
MX2007001886A (es) 2007-04-24
NZ553315A (en) 2009-12-24
US20060083753A1 (en) 2006-04-20
EP1784417B1 (en) 2016-05-18
AU2005280147B2 (en) 2011-02-24
AU2005280147A1 (en) 2006-03-09
US20080199941A1 (en) 2008-08-21
US20160355554A1 (en) 2016-12-08
EP1784417A1 (en) 2007-05-16
CA2578041C (en) 2021-03-16
ES2587365T3 (es) 2016-10-24

Similar Documents

Publication Publication Date Title
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso
BRPI0606506A2 (pt) polipeptìdeos de yersinia spp. e métodos de uso
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
BRPI0607323A2 (pt) composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo
ECSP099027A (es) Anticuerpos anti-dll4 y métodos que los usan
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
EA200602129A1 (ru) Новое применение пептидных соединений для лечения дискинезии
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
WO2005107491A3 (en) Multi-lectin affinity chromatography and uses thereof
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
UY28342A1 (es) Nuevos compuestos
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
UY28348A1 (es) Compuestos novedosos
BRPI0609765A8 (pt) mistura de isoalcano, método para a preparação da mesma, composição cosmética ou farmacêutica, e, uso de uma mistura de isoalcano
UY27894A1 (es) Derivados de cinamida.
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
EA200801414A1 (ru) Кальцилитические соединения
CR10280A (es) Anticuerpos de la efgl7 y metodos de uso
CL2011001078A1 (es) Compuestos derivados de espirodihidrotetraazabenzoazuleno; procedimiento de preparacion; composicion farmaceutica; y su uso para la prevencion o tratamiento de dismenorrea, disfuncion sexual, hipertension, cirrosis hepatica y esquizofrenia entre otras.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2153 DE 10/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11, 8O C/C 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]